Moneycontrol
HomeNewsBusinessMarketsClosing Bell: Sensex ends 159 points higher, Nifty at 10,685; Infosys up 3%
Trending Topics

Closing Bell: Sensex ends 159 points higher, Nifty at 10,685; Infosys up 3%

At the close of market hours, the Sensex ended up 159.06 points or 0.45% at 35513.14, while the Nifty was higher by 57.00 points or 0.54% at 10685.60.

November 27, 2018 / 15:36 IST
Story continues below Advertisement

November 27, 2018 / 15:36 IST

Market at Close

It’s a green close for the market on Tuesday, with the Nifty ending well above 10,650-mark.

A rally among PSU banks, energy names as well as IT boosted the market. In the broader market, the Nifty Midcap index ended over half a percent higher.

At the close of market hours, the Sensex ended up 159.06 points or 0.45% at 35513.14, while the Nifty was higher by 57.00 points or 0.54% at 10685.60. The market breadth was narrow as 1238 shares advanced, against a decline of 1320 shares, while 161 shares were unchanged.

Infosys, TCS, and BPCL were the top gainers, while Sun Pharma and Hero MotoCorp lost the most.

November 27, 2018 / 15:27 IST

PNB gains 2%

:Punjab National Bank shares gained 2.5 percent after the lender expects Rs 2,500 crore recovery from Essar Steel resolution.

Story continues below Advertisement
November 27, 2018 / 15:19 IST

Moody's has downgradedYes Bank's ratings and changed outlook to negative, reported CNBC-TV18.

November 27, 2018 / 15:12 IST

Buzzing

:63 Moons Technologies shares declined nearly 4 percent after the company sold major stake in its subsidiary to Japanese firm.

Story continues below Advertisement
November 27, 2018 / 14:59 IST

Zydus Cadila gets USFDA approval:

Zydus Cadila has received the final approval from the USFDA to market Baclofen Tablets, 10 mg and 20 mg. It will be manufactured at the group’s formulations manufacturing facility at Baddi.

November 27, 2018 / 14:47 IST

Monte Carlo Fashions buyback:

A meeting of the Board of Directors of the company is scheduled to be held on November 30 to consider and approve the buyback of fully paid-up equity shares of the company.

November 27, 2018 / 14:16 IST

Lupin gets EIR from USFDA:

The company has received EIR (Establishment Inspection Report) on the completion of an inspection by the USFDA (United States Food & DrugAdministration) at its facility in Tarapur, Maharashtra.

November 27, 2018 / 13:42 IST

MARKET UPDATE 

| At 13:40 hrs IST, the Sensex is up 92.02 points or 0.26% at 35446.10, and the Nifty up 30.90 points or 0.29% at 10659.50. The market breadth is negative as 1111 shares advanced, against a decline of 1229 shares, while 124 shares were unchanged.

Story continues below Advertisement